CBDS Cannabis Sativa Inc

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency Payments, Including Dogecoin

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency Payments, Including Dogecoin

MESQUITE, NV, Sept. 10, 2025 (GLOBE NEWSWIRE) --



September 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation,announced that its wholly owned subsidiary, PrestoDoctor, a leading telemedicine platform for medical cannabis evaluations, has begun accepting  for its services. This includes a wide range of digital assets, with an emphasis on the Company’s namesake coin, Dogecoin (DOGE). This move is part of Dogecoin Cash, Inc.’s broader strategy to embrace decentralized technologies and offer patients a more flexible, forward-looking healthcare experience. “As digital assets continue to gain broader use, we are pleased to offer our patients the convenience of paying with cryptocurrency,” said David Tobias, CEO of Dogecoin Cash, Inc. “By accepting Dogecoin and other leading cryptocurrencies, PrestoDoctor is taking another step toward aligning with the evolving preferences of our patient community.”

The accepted cryptocurrencies now include:

  • Bitcoin (BTC)
  • Ethereum (ETH)
  • USD Coin (USDC)
  • Tron (TRX)
  • Tether (USDT)
  • BNB (Binance Coin)
  • Dogecoin (DOGE)
  • Litecoin (LTC)
  • Monero (XMR)
  • Polygon (MATIC)
  • Bitcoin Cash (BCH)
  • Shiba Inu (SHIB)
  • Solana (SOL)
  • DAI

With the integration of these cryptocurrencies, PrestoDoctor aims to make medical cannabis evaluations more accessible to a broader and more tech-savvy patient base, particularly those already engaged with blockchain-based finance.

Traditional payment methods such as credit cards and debit cards will continue to be supported, ensuring all patients can choose the payment method that best suits their needs.

“The integration of crypto payments isn’t just about convenience; it’s about staying ahead of the curve and offering enhanced privacy for our patients,” added Kyle Powers, CEO. “We believe this positions PrestoDoctor to better adapt to the changing landscape of both healthcare and digital finance.”

About Dogecoin Cash, Inc.

Dogecoin Cash, Inc. (OTCQB: DOGP) is a publicly traded company focused on the advancement of blockchain technology and its practical applications in healthcare, finance, and consumer services. Through its subsidiary PrestoDoctor, the Company provides telemedicine solutions for patients seeking medical cannabis evaluations across multiple U.S. states.

 For more information about Dogecoin Cash, Inc.  visit

About PrestoDoctor

PrestoDoctor is a leader in online medical cannabis evaluations, offering secure, HIPAA-compliant telemedicine services that connect patients with licensed physicians in a convenient and discreet manner.

For more information, please visit 

Forward Looking Statement

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as may be disclosed in the Company's filings. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release, and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. Such forward-looking statements are risks that are detailed on the Company's website and filings. This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those projected. For a detailed discussion of these risks and uncertainties, please refer to Dogecoin Cash, Inc.'s filings with the SEC.



























EN
10/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cannabis Sativa Inc

 PRESS RELEASE

Dogecoin Cash Inc. (OTCQB:DOGP) Announces Special Distribution of Doge...

Dogecoin Cash Inc. (OTCQB:DOGP) Announces Special Distribution of DogeCoin Cash (MEMECOIN:DOG) to Shareholders MESQUITE, NV, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV  — Dogecoin Cash Inc. (OTCQB:DOGP) today announced that its Board of Directors has approved a special distribution of DogeCoin Cash (MEMECOIN:DOG) to shareholders of record as of December 15, 2025. The pro rata distribution will be payable on December 22, 2025. Each shareholder of record will receive one DogeCoin Cash (MEMECOIN:DOG) for every share of Dogecoin Cash Inc. (OTCQB:DOGP) common stock held. In total, appr...

 PRESS RELEASE

Dogecoin Cash, Inc. (OTCQB: DOGP) Subsidiary PrestoDoctor Expands Tele...

Dogecoin Cash, Inc. (OTCQB: DOGP) Subsidiary PrestoDoctor Expands Telehealth Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide Now Operating in 19 States Nationwide Las Vegas, NV, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide Mesquite, NV — September 26, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP today announced that its subsidiary PrestoDoctor, a leading telemedicine platform for medical cannabis evaluations, is expanding services to Connecticut. With this addition, PrestoDoctor now operates i...

 PRESS RELEASE

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency...

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency Payments, Including Dogecoin MESQUITE, NV, Sept. 10, 2025 (GLOBE NEWSWIRE) -- September 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation,announced that its wholly owned subsidiary, PrestoDoctor, a leading telemedicine platform for medical cannabis evaluations, has begun accepting  for its services. This includes a wide range of digital assets, with an emphasis on the Company’s namesake coin, Dogecoin (DOGE). This move is part of Dogecoin Cash, Inc.’s broader st...

 PRESS RELEASE

Dogecoin Cash, Inc. Announces PrestoDoctor’s Expansion into Three New ...

Dogecoin Cash, Inc. Announces PrestoDoctor’s Expansion into Three New Markets Arizona, Massachusetts, and Virginia Mesquite, NV, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a publicly traded company focused on telehealth services and blockchain-based innovation, today announced that its wholly owned subsidiary, PrestoDoctor,  () has expanded operations into three additional U.S. states: Arizona, Massachusetts, and Virginia, offering access to secure, legally valid online consultations for medical cannabis evaluations. This expansion results in the availability...

 PRESS RELEASE

Dogecoin Cash Inc. Confirms Filing of Provisional Patent for Dogecoin ...

Dogecoin Cash Inc. Confirms Filing of Provisional Patent for Dogecoin Protocol Framework USPTO Application No. 63/849,485, dated July 23, 2025 MESQUITE, NV, July 28, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV – July 28, 2025 – Dogecoin Cash Inc. (OTCQB: DOGP) announced today that a U.S. provisional patent application has been filed with the United States Patent and Trademark Office (USPTO) for a software framework titled “Modular Blockchain–Agnostic Application Framework with Native Dogecoin Transaction Layer,”informally known as the Dogecoin Protocol (DogP). Filed under 35 U.S.C. § 111(b...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch